Tsuji Daiki 辻大樹

… Alternative Names

TSUJI Daiki 辻大樹

Less

Researcher Number	90565615
Other IDs	https://orcid.org/0000-0001-8894-2841
Affiliation (Current)	2025: 静岡県立大学, 薬学部, 教授
Affiliation (based on the past Project Information) *help	2016 – 2024: 静岡県立大学, 薬学部, 講師 2012 – 2015: 静岡県立大学, 薬学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 47060:Clinical pharmacy-related / Medical pharmacy Except Principal Investigator Basic Section 47060:Clinical pharmacy-related / Medical pharmacy
Keywords	Principal Investigator 遺伝子多型 / 化学療法誘発性悪心・嘔吐 / 制吐療法 / アプレピタント / グラニセトロン / 薬物応答性 / 予測モデル / 薬物有害反応 / 乳がん / 人種差 … More / リスク因子 / がん化学療法誘発性悪心・嘔吐 / 性差 / ゲノムバイオマーカー / CINV / オーダーメイド医療 / パロノセトロン / 薬理遺伝学 / オーダーメード医療 / 薬剤反応性 / 臨床薬理学 … More Except Principal Investigator 乳がん / 細胞外マトリクス / CSPG4 / 予後予測 / 早期診断 / 腫瘍マーカー / CSPG4自己抗体 / がんの予後モニタリング / がんの早期診断 / コンドロイチン硫酸プロテオグリカン4 / がん診断・予後モニタリング / 自己抗体 / がん関連抗原 / エピトープペプチド / ヒト型抗体 / 細胞外マトリックス / メラノーマ / リコンビナントFab / ADCC活性 / 悪性中皮腫 / すい臓がん / IgG / がん免疫組織化学 / 抗体医薬 / がん分子標的治療 Less

乳がん化学療法の有害反応予測モデルの構築とゲノムバイオマーカーの同定Principal Investigator
- Principal Investigator
  
  辻大樹
- Project Period (FY)
  2024 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  University of Shizuoka
Elucidation of gender and individual differences in chemotherapy-induced nausea and vomiting and comprehensive risk factors analysisPrincipal Investigator
- Principal Investigator
  
  Tsuji Daiki
- Project Period (FY)
  2020 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  University of Shizuoka
Construction of early diagnosis and prognosis prediction system by monitoring of cancer-related antigen CSPG4 specific autoantibodies.
- Principal Investigator
  
  ITOH Kunihiko
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  University of Shizuoka
Development of cancer therapeutic strategies targeting for extracellular matrix CSPG4.
- Principal Investigator
  
  ITOH Kunihiko
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  University of Shizuoka
Multicenter clinical study with genetic polymorphisms analysis for the individualized antiemetic treatment.Principal Investigator
- Principal Investigator
  
  Tsuji Daiki
- Project Period (FY)
  2014 – 2015
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  University of Shizuoka
Establishment of personalized antiemetic treatment based on genetic polymorphismsPrincipal Investigator
- Principal Investigator
  
  TSUJI Daiki
- Project Period (FY)
  2012 – 2013
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  University of Shizuoka

All 2023 2022 2021 2020 2016 2015 2014 2013 2012 Other

All Journal Article Presentation

[Journal Article] A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I-2023
- Author(s)
  Tsuji Daiki、Nakagaki Shigeru、Yonezawa Itsuki、Suzuki Kenichi、Yokokawa Takashi、Kawasaki Yohei、Yamaguchi Takumi、Kawaguchi Takashi、Hatori Masahiro、Matsumoto Takuma、Sakata Yukio、Yamamoto Keisuke、Nishimura Tomoyasu、Kogure Yuki、Hayashi Toshinobu、Osawa Misa、Itoh Kunihiko、Watanabe Masaya
- Journal Title
  
  Investigational New Drugs
  
  Volume: 42 Issue: 1 Pages: 44-52
- DOI
  10.1007/s10637-023-01414-y
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K07179
[Journal Article] Influence of menopause on chemotherapy‐induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study2023
- Author(s)
  Yokokawa Takashi、Suzuki Kenichi、Tsuji Daiki、Hosonaga Mari、Kobayashi Kazuo、Kawakami Kazuyoshi、Kawazoe Hitoshi、Nakamura Tomonori、Suzuki Wataru、Sugisaki Takahito、Aoyama Takeshi、Hashimoto Koki、Hatori Masahiro、Tomomatsu Takuya、Inoue Ayaka、Azuma Keiichi、Asano Maimi、Takano Toshimi、Ohno Shinji
- Journal Title
  
  Cancer Medicine
  
  Volume: 12 Issue: 18 Pages: 18745-18754
- DOI
  10.1002/cam4.6494
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K07179
[Journal Article] Results of a nationwide survey of Japanese pharmacists regarding the application of pharmacogenomic testing in precision medicine2021
- Author(s)
  Daiki Tsuji, Yoshiro Saito, Taisei Mushiroda, Masatomo Miura, Daiki Hira, Tomohiro Terada
- Journal Title
  
  J Clin Pharm Ther
  
  Volume: 46 Pages: 649-657
- NAID
  120006974981
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K07179
[Journal Article] Pharmacogenetics of antiemetics for chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis2020
- Author(s)
  Eliasen Astrid、Dalhoff Kim、Mathiasen Ren、Schmiegelow Kjeld、Rechnitzer Catherine、Schelde Astrid Blicher、Perwitasari Dyah Aryani、Tsuji Daiki、Brok Jesper
- Journal Title
  
  Critical Reviews in Oncology/Hematology
  
  Volume: 149 Pages: 102939-102939
- DOI
  10.1016/j.critrevonc.2020.102939
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K07179
[Journal Article] Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study2016
- Author(s)
  Tsuji D, Yokoi M, Suzuki K, Daimon T, Nakao M, Ayuhara H, Kogure Y, Shibata K, Hayashi T, Hirai K, Inoue K, Hama T, Takeda K, Nishio M, Itoh K.
- Journal Title
  
  Pharmacogenomics J.
  
  Volume: -
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-26860110
[Journal Article] Association of ABCB1 polymorphisms with the antiemetic efficacy of granisetron plus dexamethasone in breast cancer patients2013
- Author(s)
  Tsuji D, Kim Y-Il, Nakamich H, Daimon T, Suwa K, Iwabe Y, Hayashi H, Inoue K, Yoshida M, Itoh K
- Journal Title
  
  Drug Metab. Pharmacokinet
  
  Volume: 28 Pages: 299-304
- NAID
  50008758067
- Data Source
  KAKENHI-PROJECT-24790162
[Journal Article] Association of ABCB1 polymorphisms with the antiemetic efficacy of granisetron plus dexamethasone in breast cancer patients.2013
- Author(s)
  Tsuji D, Kim Y-Il, Nakamich H, Daimon T, Suwa K, Iwabe Y, Hayashi H, Inoue K, Yoshida M, Itoh K
- Journal Title
  
  Drug Metab. Pharmacokinet.,
  
  Volume: 28 Pages: 299-304
- NAID
  50008758067
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24790162
[Journal Article] 薬剤師主導臨床試験の立案2012
- Author(s)
  辻大樹、伊藤邦彦
- Journal Title
  
  薬局
  
  Volume: 63 Pages: 144-151
- Data Source
  KAKENHI-PROJECT-24790162
[Presentation] A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for cisplatin-containing regimen2023
- Author(s)
  Shigeru Nakagaki, Daiki Tsuji, Itsuki Yonezawa, Misa Osawa, Kenichi Suzuki, Takumi Yamaguchi, Yohei Kawasaki, Takashi Kawaguchi, Takashi Yokokawa, Takuma Matsumoto, Yukio Sakata, Keisuke Yamamoto, Tomoyasu Nishimura, Yuki Kogure, Toshinobu Hayashi, Kunihiko Itoh, Masaya Watanabe:
- Organizer
  Multinational Association of Supportive Care in Cancer 2023 Annual Meeting
- Data Source
  KAKENHI-PROJECT-20K07179
[Presentation] 乳癌高度催吐性化学療法に対する制吐療法の多施設共同第II相臨床試験2023
- Author(s)
  鈴木亘、川口崇、辻大樹、横川貴志、川崎洋平、山口拓允、高田慎也、玉木慎也、小泉圭、松本拓真、坂田幸雄、荒川雄一朗、鮎原秀明、山口正和、鈴木賢一
- Organizer
  第61回日本癌治療学会学術集会
- Data Source
  KAKENHI-PROJECT-20K07179
[Presentation] A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for highly emetogenic chemotherapy in breast cancer2023
- Author(s)
  Shinya Takada, Daiki Tsuji, Takashi Kawaguchi, Takashi Yokokawa, Yohei Kawasaki, Takumi Yamaguchi, Shinya Tamaki, Kei Koizumi, Takuma Matsumoto, Yukio Sakata, Yuichiro Arakawa, Hideaki Ayuhara, Masakazu Yamaguchi, Wataru Suzuki, Kenichi Watanabe, Mari Hosonaga, Shigeru Nakagaki, Misa Osawa, Kenichi Suzuki:
- Organizer
  European Society for Medical Oncology (ESMO) 2023 Congress
- Data Source
  KAKENHI-PROJECT-20K07179
[Presentation] シスプラチン投与に対するステロイドフリーによる制吐療法の有効性および安全性の検討2023
- Author(s)
  坂田幸雄、吉田壘、神佳祐、村永諒、山本いずみ、中嶋紘文、辻大樹、小林道
- Organizer
  第16 回日本緩和医療薬学会年会
- Data Source
  KAKENHI-PROJECT-20K07179
[Presentation] 多機関共同研究とキャリアパス：薬学部臨床系教員としての活動2023
- Author(s)
  辻　大樹
- Organizer
  日本薬学会第143年会
- Data Source
  KAKENHI-PROJECT-20K07179
[Presentation] 化学療法誘発性悪心・嘔吐の発現と閉経及び悪阻との関連の解析2022
- Author(s)
  米澤樹、辻大樹、小玉千佳、松本恵実、山本圭祐、鈴木　賢一、宮城壮裕、中道秀徳、矢部勝茂、伊藤邦彦
- Organizer
  日本臨床腫瘍薬学会　学術大会2022
- Data Source
  KAKENHI-PROJECT-20K07179
[Presentation] 静岡県で実施したグラニセトロン3 mgに対する1 mgのランダム化二重盲検非劣性試験2022
- Author(s)
  辻　大樹
- Organizer
  日本臨床腫瘍薬学会　学術大会2022
- Data Source
  KAKENHI-PROJECT-20K07179
[Presentation] 化学療法誘発性悪心・嘔吐の発現に影響する遺伝的因子の統合解析2021
- Author(s)
  小玉千佳、辻大樹、山本圭祐、米澤樹、宮城壮裕、中道秀徳、矢部勝茂、伊藤邦彦
- Organizer
  第31回日本医療薬学会年会
- Data Source
  KAKENHI-PROJECT-20K07179
[Presentation] Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy of triple antiemetic combination with aprepitant in cancer patients receiving cisplatin-based chemotherapy: TRIPLE Pharmacogenomics Study2015
- Author(s)
  Suzuki K, Tsuji D, Yokoi M, Daimon T, Nakao M, Ayuhara H, Kogure Y, Shibata K, Hayashi T, Hirai K, Inoue K, Hama T, Takeda K, Nishio M, Itoh K.
- Organizer
  European Cancer Congress 2015
- Place of Presentation
  Vienna
- Year and Date
  2015-09-25
- Data Source
  KAKENHI-PROJECT-26860110
[Presentation] CDDP 誘発性悪心・嘔吐患者における ABCB1 および ABCG2 遺伝子多型の制吐効果に与える影響2015
- Author(s)
  中尾將彦、辻大樹、鈴木賢一、横井茉里、大門貴志、鮎原秀明、小暮友毅、柴田和彦、林稔展、武田晃司、西尾誠人、濱敏弘、伊藤邦彦
- Organizer
  第53回年日本癌治療学会学術集会
- Place of Presentation
  京都
- Year and Date
  2015-10-29
- Data Source
  KAKENHI-PROJECT-26860110
[Presentation] 遺伝子多型情報を活用した有害反応発現のリスク因子解析‐薬剤部との連携による臨床研究の実践‐2015
- Author(s)
  辻大樹、塩川満、鈴木賢一、伊藤邦彦
- Organizer
  第25回日本医療薬学会年会
- Place of Presentation
  横浜
- Year and Date
  2015-11-21
- Data Source
  KAKENHI-PROJECT-26860110
[Presentation] 病院薬剤師の臨床研究はここまで来た！2014
- Author(s)
  辻　大樹
- Organizer
  病院・薬局薬剤師・薬学部臨床系教員のための臨床研究セミナー2014
- Place of Presentation
  東京
- Year and Date
  2014-11-22
- Invited
- Data Source
  KAKENHI-PROJECT-26860110
[Presentation] 背景となるエビデンスが乏しいとき～薬剤師が主体となって行う臨床研究の意義～2014
- Author(s)
  辻　大樹
- Organizer
  第24回年日本医療薬学会年会
- Place of Presentation
  名古屋
- Year and Date
  2014-09-28
- Invited
- Data Source
  KAKENHI-PROJECT-26860110
[Presentation] がん薬物療法の毒性と対応 : 嘔気・嘔吐2013
- Author(s)
  辻大樹
- Organizer
  第2回蔵王・がん薬物療法シンポジウム
- Place of Presentation
  宮城
- Year and Date
  2013-04-20
- Data Source
  KAKENHI-PROJECT-24790162
[Presentation] 化学療法誘発性悪心・嘔吐発現におけるリスク因子の解析2012
- Author(s)
  辻大樹、岩部悠太郎、大門貴志、渡辺昌也、多久佳成、内田恭之、青島広明、安井博史、伊藤邦彦、山本信之、朴成和、金容壱
- Organizer
  第50回日本癌治療学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2012-10-26
- Data Source
  KAKENHI-PROJECT-24790162
[Presentation] 中等度催吐性化学療法誘発性悪心・嘔吐の日本人におけるリスク因子の検討2012
- Author(s)
  岩部悠太郎、辻大樹、大門貴志、林秀樹、井上和幸、伊藤邦彦
- Organizer
  第58回日本薬学会東海支部総会・大会
- Place of Presentation
  静岡
- Year and Date
  2012-07-07
- Data Source
  KAKENHI-PROJECT-24790162
[Presentation] 高度催吐性化学療法誘発性悪心嘔吐におけるABCトランスポーター遺伝子多型解析2012
- Author(s)
  辻大樹、岩部悠太郎、金容壱、中道秀徳、都甲海、亀里真那、羽鳥正浩、池田翠、林秀樹、井上和幸、伊藤邦彦
- Place of Presentation
  静岡
- Year and Date
  2012-09-25
- Data Source
  KAKENHI-PROJECT-24790162
[Presentation] がん薬物療法の毒性とその対応:嘔気・嘔吐
- Author(s)
  辻　大樹
- Organizer
  第2回蔵王・がん薬物療法シンポジウム
- Place of Presentation
  宮城
- Invited
- Data Source
  KAKENHI-PROJECT-24790162
[Presentation] Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy of a triple antiemetic combination in cancer patients receiving cisplatin-based chemotherapy: TRIPLE Pharmacogenomics Study
- Author(s)
  K. Suzuki, D. Tsuji, M. Yokoi, T. Daimon, M. Nakao, H. Ayuhara, Y. Kogure, K. Shibata, T. Hayashi, K. Takeda, M. Nishio, T. Hama, K. Itoh
- Organizer
  European Cancer Congress 2015
- Place of Presentation
  Vienna
- Year and Date
  2015-09-25 – 2015-09-29
- Data Source
  KAKENHI-PROJECT-26860110
[Presentation] 中等度催吐性化学療法誘発性悪心・嘔吐の日本人におけるリスク因子の検討
- Author(s)
  岩部悠太郎、辻　大樹、大門貴志、林　秀樹、井上和幸、伊藤邦彦
- Organizer
  第58回日本薬学会東海支部総会・大会
- Place of Presentation
  静岡
- Data Source
  KAKENHI-PROJECT-24790162
[Presentation] CDDP 誘発性悪心・嘔吐患者における ABCB1 および ABCG2 遺伝子多型の制吐効果に与える影響
- Author(s)
  中尾將彦、辻大樹、鈴木賢一、横井茉里、大門貴志、鮎原秀明、小暮友毅、柴田和彦、林稔展、武田晃司、西尾誠人、濱敏弘、伊藤邦彦
- Organizer
  第53回日本癌治療学会
- Place of Presentation
  京都
- Year and Date
  2015-10-29 – 2015-10-31
- Data Source
  KAKENHI-PROJECT-26860110
[Presentation] 化学療法誘発性悪心・嘔吐発現におけるリスク因子の解析
- Author(s)
  辻　大樹、岩部悠太郎、大門貴志、渡辺昌也、多久佳成、内田恭之、青島広明、安井博史、伊藤邦彦、山本信之、朴　成和、金　容壱
- Organizer
  第50回日本癌治療学会学術集会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-24790162

1. ITOH Kunihiko (90221770)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
2. 井上和幸 (90514589)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
3. 平井啓太 (30740203)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. 中谷英仁 (80627670)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Tsuji Daiki 辻 大樹

TSUJI Daiki 辻 大樹

Research Projects

Research Products

Co-Researchers

乳がん化学療法の有害反応予測モデルの構築とゲノムバイオマーカーの同定Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Elucidation of gender and individual differences in chemotherapy-induced nausea and vomiting and comprehensive risk factors analysisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Construction of early diagnosis and prognosis prediction system by monitoring of cancer-related antigen CSPG4 specific autoantibodies.

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of cancer therapeutic strategies targeting for extracellular matrix CSPG4.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Multicenter clinical study with genetic polymorphisms analysis for the individualized antiemetic treatment.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Establishment of personalized antiemetic treatment based on genetic polymorphismsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I-2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Influence of menopause on chemotherapy‐induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Results of a nationwide survey of Japanese pharmacists regarding the application of pharmacogenomic testing in precision medicine2021

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Pharmacogenetics of antiemetics for chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study2016

Author(s)

Journal Title

Data Source

[Journal Article] Association of ABCB1 polymorphisms with the antiemetic efficacy of granisetron plus dexamethasone in breast cancer patients2013

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Association of ABCB1 polymorphisms with the antiemetic efficacy of granisetron plus dexamethasone in breast cancer patients.2013

Author(s)

Journal Title

NAID

Data Source

[Journal Article] 薬剤師主導臨床試験の立案2012

Author(s)

Journal Title

Data Source

[Presentation] A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for cisplatin-containing regimen2023

Tsuji Daiki 辻大樹

TSUJI Daiki 辻大樹

[Presentation] 背景となるエビデンスが乏しいとき～薬剤師が主体となって行う臨床研究の意義～2014